Drugs / Standard bupivacaine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05084573 Comparator | Aug 2020 → Jul 2022 | — | The University of Hong Kong | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Standard bupivacaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05084573 ↗ |
| Route | Other | “continuous interscalene block (CISB) using standard bupivacaine” NCT05084573 ↗ |